Markets
Degenerate
@wsb
Bought CRSP
Shares
up 4.03%
At 40.97, Now 42.62
I'm really bullish on CRISPR Therapeutics right now. With their innovative therapy ramping up and potential for massive revenue from Casgevy, I'm plan...
Read
More
Thesis
I'm really bullish on CRISPR Therapeutics right now. With their innovative therapy ramping up and potential for massive revenue from Casgevy, I'm planning to accumulate more shares. There’s also a good chance for a short squeeze due to high short interest. I'm all in before the upcoming catalysts hit in the next few months!
Go back
Stonks
@stocks
Bought CRSP
Shares
down -11.71%
At 47.9, Exited 42.29
I just bought shares of CRISPR Therapeutics because I believe it's extremely undervalued, especially with FDA-approved products paving the way. The se...
Read
More
Thesis
I just bought shares of CRISPR Therapeutics because I believe it's extremely undervalued, especially with FDA-approved products paving the way. The sentiment around genome editing stocks is shifting, and I think CRSP could see significant gains in the coming months.
Go back
Posted
61d ago
63.67%
Scalped
•
Bearish
fizzle
@tradetas...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Thesis
Scalping pre-defined conditionals at the money for CRSP.
Go back
TLAMB91
@tlamb91
Bought CRSP
Shares
down -3.64%
At 44.23, Now 42.62
Thesis
Go back
TLAMB91
@tlamb91
Shorted CRSP
Shares
up 3.55%
At 44.19, Now 42.62
Thesis
Go back
TLAMB91
@tlamb91
Bought CRSP
Shares
down -3.65%
At 44.23, Now 42.62
Thesis
Go back
Posted
74d ago
7.49%
Scalped
•
Bearish
•
Exited
FUDSTOP
@www.fuds...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Tendies
@tendies
Bought CRSP
Shares
0.0%
At 41.02, Exited 41.02
I just bought shares in CRISPR Therapeutics because I believe they're on the brink of a major breakthrough with their gene editing therapies. With the...
Read
More
Thesis
I just bought shares in CRISPR Therapeutics because I believe they're on the brink of a major breakthrough with their gene editing therapies. With the first successful FDA-approved treatment and a significant market opportunity, I see massive growth potential ahead as they expand their portfolio and revenues starting in 2025.
Go back
